The Dexcom Stelo CGM was FDA-approved in March for adults with type 2 diabetes who are not on insulin, and it’s now available for purchase without a prescription. Stelo sends continuous blood sugar readings to a smartphone 24/7, revealing how food, exercise, and sleep can affect your blood glucose. It’s an empowering tool to help people with T2D better understand how glucose affects their health.
read more →
Diabetes and cancer may have a greater association than we previously knew. The connection between type 2 diabetes in particular and certain types of cancer may be due to shared risk factors, but news from a recent study showed that GLP-1 medications may help lower risk for certain types of cancer when compared to insulin.
read more →
Dr. E’s new patient Frank has lived with type 2 diabetes for over 20 years, and despite taking all his medications, his diabetes (and other related health conditions) are getting worse, not better. Dr. E suspects Frank has a common condition that unfortunately goes undiagnosed for years in many patients.
read more →Dr. Edelman helps a patient who has Flatbush Diabetes (also known as Ketosis-Prone Diabetes) which is a unique subtype of type 2 diabetes.
read more →
The over-the-counter CGM market has two new players…the Lingo and Libre Rio. The two systems created by Abbott were intentionally designed to meet different needs – Lingo for those who want to better understand and improve their health and wellness, and Libre Rio for adults with type 2 diabetes who do not use insulin and typically manage their diabetes through lifestyle modifications.
read more →Dr. E’s new patient William had diligently followed advice from his primary care provider that unfortunately kept his blood sugars high all day, every day for many years. Thankfully Dr. E was able to help William turn things around with a few simple tools and strategies.
read more →
For years and years (and years), the “red suitcase” was the main glucagon rescue kit most people with type 1 diabetes had stashed somewhere in case of emergency. Thankfully, we now have two newer glucagon options that are much easier to administer. Drs. E+P explain how to use each one, and they discuss the research and off-label mini-dose glucagon experiments people are conducting that may be a mirror into the future.
read more →
Up until now, it’s been difficult for people newly diagnosed with type 2 diabetes, or those not on inulin, to get CGM covered by insurance. Thanks to the FDA’s recent approval of Dexcom Stelo – a CGM that can be purchased over-the-counter without a prescription – people with type 2 diabetes who are not on insulin will now be able to benefit from invaluable CGM technology.
read more →
